rdf:type |
|
lifeskim:mentions |
umls-concept:C0003250,
umls-concept:C0012655,
umls-concept:C0017262,
umls-concept:C0019628,
umls-concept:C0021747,
umls-concept:C0024348,
umls-concept:C0041361,
umls-concept:C0086418,
umls-concept:C0127400,
umls-concept:C0185117,
umls-concept:C0439662,
umls-concept:C0439849,
umls-concept:C0443199,
umls-concept:C1280500,
umls-concept:C1513095,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
1981-9-15
|
pubmed:abstractText |
Incubation of cultured human melanoma cells with human leukocyte interferon did not change the expression of melanoma-associated antigens (MAA) recognized by monoclonal antibodies and of Ia-like antigens but significantly increased the expression of HLA-A,B antigens and of beta 2-microglobulin (beta 2-mu). The effect is dependent on the dose of interferon and on the incubation time. Interferon-treated melanoma cells showed an increased susceptibility to lysis mediated by monoclonal antibodies to HLA-A,B antigens and to human beta 2-mu; on the other hand, interferon-treated melanoma cells did not change in their susceptibility to murine natural killer (NK) cell lysis and to immune lysis mediated by monoclonal antibodies to MAA and to Ia-like antigens, and they displayed a reduced susceptibility to human NK cell lysis. Therefore, the increased susceptibility of interferon-treated melanoma cells to lysis mediated by anti HLA-A,B and anti beta 2-mu monoclonal antibodies is likely to reflect the increase in cell surface expression of the corresponding antigens.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1767
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
127
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
505-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6166672-Animals,
pubmed-meshheading:6166672-Antibodies,
pubmed-meshheading:6166672-Antibodies, Monoclonal,
pubmed-meshheading:6166672-Antigens, Neoplasm,
pubmed-meshheading:6166672-Binding Sites, Antibody,
pubmed-meshheading:6166672-Cytotoxicity, Immunologic,
pubmed-meshheading:6166672-HLA Antigens,
pubmed-meshheading:6166672-Histocompatibility Antigens Class II,
pubmed-meshheading:6166672-Humans,
pubmed-meshheading:6166672-Interferons,
pubmed-meshheading:6166672-Melanoma,
pubmed-meshheading:6166672-Mice,
pubmed-meshheading:6166672-Mice, Inbred BALB C,
pubmed-meshheading:6166672-Mice, Inbred C3H,
pubmed-meshheading:6166672-Rosette Formation
|
pubmed:year |
1981
|
pubmed:articleTitle |
Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|